Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sang Hee Park, Gary Binder, Shelby Corman & Marc Botteman. (2019) Budget impact of netupitant/palonosetron for the prevention of chemotherapy-induced nausea and vomiting. Journal of Medical Economics 22:8, pages 840-847.
Read now
Read now
Rudolph M Navari & Lee S Schwartzberg. (2018) Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting. OncoTargets and Therapy 11, pages 6459-6478.
Read now
Read now
Lee Schwartzberg. (2014) Addressing the value of novel therapies in chemotherapy-induced nausea and vomiting. Expert Review of Pharmacoeconomics & Outcomes Research 14:6, pages 825-834.
Read now
Read now
Articles from other publishers (31)
Marco Filetti, Pasquale Lombardi, Raffaele Giusti, Rosa Falcone, Florian Scotte, Diana Giannarelli, Antonella Carcagnì, Valeria Altamura, Giovanni Scambia & Gennaro Daniele. (2023) Efficacy and safety of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: A systematic review and network meta-analysis. Cancer Treatment Reviews 115, pages 102512.
Crossref
Crossref
Nikolai A. Ognerubov. (2023) Fosaprepitant: current options to prevent chemotherapy-induced nausea and vomiting: A review. Journal of Modern Oncology 24:4, pages 477-486.
Crossref
Crossref
Jonas Nilsson, Vittoria Piovesana, Marco Turini, Claudio Lezzi, Jennifer Eriksson & Matti Aapro. (2022) Cost-effectiveness analysis of NEPA, a fixed-dose combination of netupitant and palonosetron, for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting: an international perspective. Supportive Care in Cancer 30:11, pages 9307-9315.
Crossref
Crossref
Nilofar Pasyar, Masoume Rambod, Fatemeh Zahedi & Mani Ramzi. (2022) Pain, Fatigue, Nausea, and Vomiting as the Predictors of Anxiety in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study. Supportive Care in Cancer 30:7, pages 5871-5879.
Crossref
Crossref
Abu Saleh Mohammad Mosa, Md Kamruz Zaman Rana, Humayera Islam, A K M Mosharraf Hossain & Illhoi Yoo. (2021) A Smartphone-Based Decision Support Tool for Predicting Patients at Risk of Chemotherapy-Induced Nausea and Vomiting: Retrospective Study on App Development Using Decision Tree Induction. JMIR mHealth and uHealth 9:12, pages e27024.
Crossref
Crossref
Ronald Chow, Leonard Chiu, Jørn Herrstedt, Matti Aapro, Michael Lock, Carlo DeAngelis & Rudolph M. Navari. (2021) Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patients. Supportive Care in Cancer 29:8, pages 4269-4275.
Crossref
Crossref
Abu Saleh Mohammad Mosa, Akm Mosharraf Hossain & Illhoi Yoo. (2020) A dynamic prediction engine to prevent chemotherapy-induced nausea and vomiting. Artificial Intelligence in Medicine 109, pages 101925.
Crossref
Crossref
Bharat Vaswani, Sagar Bhagat, Saiprasad Patil & Hanmant Barkate. (2020) Effectiveness of a novel, fixed dose combination of netupitant and palonosetron in prevention of chemotherapy induced nausea and vomiting: A real-life study from India. World Journal of Clinical Oncology 11:8, pages 606-613.
Crossref
Crossref
Rudolph M Navari & Eric J Roeland. (2020) Unscheduled hydrations: redefining complete response in chemotherapy-induced nausea and vomiting studies. Future Oncology 16:24, pages 1863-1872.
Crossref
Crossref
Daniel Rosas & Luis E. Raez. (2020) Anaphylactic Shock and Cardiac Arrest Secondary to Aprepitant. American Journal of Therapeutics 27:6, pages e640-e642.
Crossref
Crossref
Nirosha Mahendraratnam, Joel F. Farley, Ethan Basch, Amber Proctor, Stephanie B. Wheeler & Stacie B. Dusetzina. (2019) Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy. Supportive Care in Cancer 27:12, pages 4525-4534.
Crossref
Crossref
Jaume Mora, Miguel Valero, Cara DiCristina, Mandy Jin, Anne Chain & Kara Bickham. (2019) Pharmacokinetics/pharmacodynamics, safety, and tolerability of fosaprepitant for the prevention of chemotherapy‐induced nausea and vomiting in pediatric cancer patients. Pediatric Blood & Cancer 66:6, pages e27690.
Crossref
Crossref
Randy Erickson, Neil Nebughr, Michael C Mosier & William Nibley. (2019) Hydration requirements in patients receiving highly emetogenic chemotherapy. Future Oncology 15:7, pages 753-761.
Crossref
Crossref
Syril D. Pettit & Rebecca Kirch. (2018) Do current approaches to assessing therapy related adverse events align with the needs of long-term cancer patients and survivors?. Cardio-Oncology 4:1.
Crossref
Crossref
Ricky McCullough. (2018) Merit-based Claim Adjudication for Cancer Treatment Toxicities – Policy Trends that Lower Downstream Costs. Journal of Insurance Medicine 47:4, pages 236-248.
Crossref
Crossref
Ricky W McCullough. (2017) US oncology-wide incidence, duration, costs and deaths from chemoradiation mucositis and antimucositis therapy benefits. Future Oncology 13:30, pages 2823-2852.
Crossref
Crossref
Ylva Widgren & Anna Enblom. (2017) Emesis in patients receiving acupuncture, sham acupuncture or standard care during chemo-radiation: A randomized controlled study. Complementary Therapies in Medicine 34, pages 16-25.
Crossref
Crossref
Anna Enblom, Gunnar Steineck, Mats Hammar & Sussanne B?rjeson. (2017) Reduced Need for Rescue Antiemetics and Improved Capacity to Eat in Patients Receiving Acupuncture Compared to Patients Receiving Sham Acupuncture or Standard Care during Radiotherapy. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-11.
Crossref
Crossref
Silvia Sommariva, Benedetta Pongiglione & Rosanna Tarricone. (2016) Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: A systematic review. Critical Reviews in Oncology/Hematology 99, pages 13-36.
Crossref
Crossref
S. Tafelski, W. Häuser & M. Schäfer. (2016) Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting—a systematic review of systematic reviewsWirksamkeit, Verträglichkeit und Sicherheit von Cannabinoiden für die Therapie von Chemotherapie-induzierter Übelkeit und Erbrechen: eine systematische Zusammenfassung systematischer Reviews. Der Schmerz 30:1, pages 14-24.
Crossref
Crossref
William Lee Hasler. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
676
694
.
Aimee L. Lucas. 2014. Mount Sinai Expert Guides. Mount Sinai Expert Guides
13
20
.
Ryan N Hansen, Scott D Ramsey, Deepa Lalla, Anthony Masaquel, Tripthi Kamath, Melissa Brammer, Sara A Hurvitz & Sean D Sullivan. (2014) Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens. SpringerPlus 3:1.
Crossref
Crossref
Lee Schwartzberg, Sally Y. Barbour, Gary R. Morrow, Gianluca Ballinari, Michael D. Thorn & David Cox. (2013) Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV). Supportive Care in Cancer 22:2, pages 469-477.
Crossref
Crossref
James W. Gilmore, Nancy W. Peacock, Anna Gu, Stephen Szabo, Melissa Rammage, Joyce Sharpe, Sally T. Haislip, Toni Perry, Tim L. Boozan, Katherine Meador, Xiting Cao & Thomas A. Burke. (2014) Antiemetic Guideline Consistency and Incidence of Chemotherapy-Induced Nausea and Vomiting in US Community Oncology Practice: INSPIRE Study. Journal of Oncology Practice 10:1, pages 68-74.
Crossref
Crossref
Alan Carlotto, Virginia L. Hogsett, Elyse M. Maiorini, Janet G. Razulis & Stephen T. Sonis. (2013) The Economic Burden of Toxicities Associated with Cancer Treatment: Review of the Literature and Analysis of Nausea and Vomiting, Diarrhoea, Oral Mucositis and Fatigue. PharmacoEconomics 31:9, pages 753-766.
Crossref
Crossref
Guy H. Montgomery, Julie B. Schnur & Kate Kravits. (2012) Hypnosis for cancer care: Over 200 years young. CA: A Cancer Journal for Clinicians 63:1, pages 31-44.
Crossref
Crossref
Hanna A. Zaghloul & Jose R. MurilloJr.Jr.. (2012) Treatment Given Near the End of Life in Castration-Resistant Prostate Cancer. American Journal of Hospice and Palliative Medicine® 29:7, pages 536-540.
Crossref
Crossref
Judith A. Smith, Paula Anastasia & Marc Rappaport. (2012) Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting with the Granisetron Transdermal System (GTDS): Three Clinical Perspectives on Three Case Studies in Solid Tumors. The Journal of Supportive Oncology 10:5, pages S1-S8.
Crossref
Crossref
Pamela Hallquist Viale, Carolyn Grande & Susan Moore. (2012) Efficacy and Cost: Avoiding Undertreatment of Chemotherapy-Induced Nausea and Vomiting. Clinical Journal of Oncology Nursing 16:4, pages E133-E141.
Crossref
Crossref
Sanjeev Balu, Deborah Buchner, Chris Craver & Julie Gayle. (2011) Palonosetron Versus Other 5-HT3 Receptor Antagonists for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer on Chemotherapy in a Hospital Outpatient Setting. Clinical Therapeutics 33:4, pages 443-455.
Crossref
Crossref